As of 05/18/2025, Biomerica's market capitalization has reached $9.27 M. According to our data, Biomerica is the 39892th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap
9.27 M
Revenue (ttm)
5.68 M
Net Income (ttm)
-4,850,000
Shares Out
2.55 M
EPS (ttm)
-2.14
Forward PE
0.00
Ex-Dividend Date
n/a
Earnings Date
04/14/2025
Market Cap Chart
Data Updated: 05/18/2025
Biomerica's yearly market capitalization.
Biomerica has seen its market value drop from $18.80 M to $9.27 M since 2016, representing a total decrease of 50.71% and an annual compound decline rate (CAGR) of 8.09%.
Date
Market Cap
Change (%)
05/18/2025
$9.27 M
82%
12/31/2024
$5 M
-76.19%
12/29/2023
$21 M
-53.33%
12/30/2022
$45 M
-7.6%
12/31/2021
$48.70 M
-16.75%
12/31/2020
$58.50 M
96.97%
12/31/2019
$29.70 M
92.86%
12/31/2018
$15.40 M
-51.72%
12/29/2017
$31.90 M
69.68%
12/30/2016
$18.80 M
Company Profile
Biomerica was founded in 1971 in United States.
on the Nasdaq Stock Market.
With 64 employees, it focuses on Healthcare and aims to drive innovation in Medical Devices.
Frequently Asked Questions
As of 05/18/2025, Biomerica (including the parent company, if applicable) has an estimated market capitalization of $9.27 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Biomerica global market capitalization ranking is approximately 39892 as of 05/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.